lif
rHu LIF |
|||
AK9977-0100 | Akron Biotech | 100µg | Ask for price |
rHu LIF |
|||
AK9977-1000 | Akron Biotech | 1mg | Ask for price |
LIF siRNA |
|||
20-abx922546 | Abbexa |
|
|
LIF siRNA |
|||
20-abx922547 | Abbexa |
|
|
LIF, human |
|||
MO16101 | Neuromics | 100 ug | 825.6 EUR |
LIF, mouse |
|||
MO16102 | Neuromics | 100 ug | 810 EUR |
LIF, Human |
|||
HY-P7049 | MedChemExpress | 10ug | 1920 EUR |
LIF, Mouse |
|||
HY-P7084 | MedChemExpress | 50ug | 639.6 EUR |
LIF protein |
|||
30R-2771 | Fitzgerald | 10 ug | 442.8 EUR |
Description: Purified recombinant Human LIF protein |
|||
LIF protein |
|||
30R-2772 | Fitzgerald | 10 ug | 586.8 EUR |
Description: Purified recombinant Mouse LIF protein |
|||
LIF Peptide |
|||
43-200P | ProSci | 0.1 mg | 405.6 EUR |
LIF Peptide |
|||
6245P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) LIF peptide |
|||
LIF Antibody |
|||
25283-100ul | SAB | 100ul | 468 EUR |
LIF Antibody |
|||
6245-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
LIF Antibody |
|||
6245-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
LIF antibody |
|||
70R-12299 | Fitzgerald | 100 ug | 483.6 EUR |
Description: Rabbit polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-14100 | Fitzgerald | 100 ug | 386.4 EUR |
Description: Affinity purified Rabbit polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-6230 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal LIF antibody |
|||
LIF antibody |
|||
70R-51295 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal LIF antibody |
|||
LIF Antibody |
|||
36950-100ul | SAB | 100ul | 302.4 EUR |
LIF Antibody |
|||
5216-100 | Biovision | each | 379.2 EUR |
LIF Antibody |
|||
5216-30T | Biovision | each | 175.2 EUR |
LIF Antibody |
|||
1-CSB-PA004761 | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
LIF Antibody |
|||
1-CSB-PA198481 | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
|||
LIF Antibody |
|||
DF13730 | Affbiotech | 100ul | 420 EUR |
LIF Antibody |
|||
1-CSB-PA012928ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
LIF Antibody |
|||
F49998-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
LIF Antibody |
|||
F49998-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
LIF antibody |
|||
PAab09804 | Lifescience Market | 100 ug | 463.2 EUR |
LIF Antibody |
|||
R36251-100UG | NSJ Bioreagents | 100 ug | 339.15 EUR |
Description: Additional name(s) for this target protein: Leukemia inhibitory factor |
|||
LIF Antibody |
|||
R30639 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. It is produced in high amounts by the human endometrium and the trophoblast itself, and its receptors are present on cytotrophoblast cells. LIF could thus play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. |
|||
LIF Antibody |
|||
R31467 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. This gene is mapped to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. It could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. |
|||
LIF Rabbit pAb |
|||
A1288-100ul | Abclonal | 100 ul | 369.6 EUR |
LIF Rabbit pAb |
|||
A1288-200ul | Abclonal | 200 ul | 550.8 EUR |
LIF Rabbit pAb |
|||
A1288-20ul | Abclonal | 20 ul | 219.6 EUR |
LIF Rabbit pAb |
|||
A1288-50ul | Abclonal | 50 ul | 267.6 EUR |
anti- LIF antibody |
|||
FNab09804 | FN Test | 100µg | 658.5 EUR |
Description: Antibody raised against LIF |
|||
anti- LIF antibody |
|||
LSMab09804 | Lifescience Market | 100 ug | 463.2 EUR |
Recombinant Rat LIF |
|||
REOPP-1201 | Cyagen | 5ug | Ask for price |
LIF Blocking Peptide |
|||
20-abx064170 | Abbexa |
|
|
LIF Blocking Peptide |
|||
33R-4712 | Fitzgerald | 100 ug | 216 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody, catalog no. 70R-6230 |
|||
LIF, human recombinant |
|||
4923-10 | Biovision | each | 366 EUR |
LIF, human recombinant |
|||
4923-1000 | Biovision | each | 6846 EUR |
LIF, human recombinant |
|||
4923-50 | Biovision | each | 796.8 EUR |
Recombinant Human LIF |
|||
HEOPP-1202 | Cyagen | 5ug | Ask for price |
LIF, murine recombinant |
|||
4924-10 | Biovision | each | 444 EUR |
LIF, murine recombinant |
|||
4924-1000 | Biovision | each | 8203.2 EUR |
Recombinant Murine LIF |
|||
MEOPP-1201 | Cyagen | 5ug | Ask for price |
Polyclonal LIF Antibody |
|||
APR06696G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal LIF Antibody |
|||
APR00279G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications: |
|||
LIF Conjugated Antibody |
|||
C36950 | SAB | 100ul | 476.4 EUR |
LIF Recombinant Protein |
|||
40-682 | ProSci | 5 ug | 311.1 EUR |
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Murine LIF is a 19.9 kDa protein containing 180 amino acids residues, including three disulfide bonds. |
|||
LIF Recombinant Protein |
|||
40-684 | ProSci | 5 ug | 311.1 EUR |
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Human LIF is a 19.7 kDa protein containing 180 amino acid residues, including three disulfide bonds. |
|||
LIF Polyclonal Antibody |
|||
41551-100ul | SAB | 100ul | 302.4 EUR |
LIF Polyclonal Antibody |
|||
41551-50ul | SAB | 50ul | 224.4 EUR |
LIF Recombinant Protein |
|||
91-014 | ProSci | 0.05 mg | 651.3 EUR |
Description: Leukemia Inhibitory Factor (LIF) is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Human and murine mature LIF exhibit a 78% sequence identity at the amino acid level. Human LIF is equally active on human and mouse cells. Murine LIF is approximately 1000 fold less active on human cells than human LIF. |
|||
LIF Recombinant Protein |
|||
91-575 | ProSci | 0.05 mg | 588.3 EUR |
Description: Mouse Leukemia inhibitory factor(lif)is a secreted protein which belongs to the LIF/OSM family.LIF has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. it has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes. |
|||
LIF Recombinant Protein |
|||
97-011 | ProSci | 0.02 mg | 468.6 EUR |
Description: Leukemia inhibitory factor, or LIF, an interleukin 6 class cytokine, is a protein in cells that affects cell growth and development.Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. Therefore LIF is used in mouse embryonic stem cell culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for LIF independent growth, notably overexpression of the gene Nanog. LIF is not required for culture of human embryonic stem cells. |
|||
LIF Recombinant Protein |
|||
90-277 | ProSci | 10 ug | 405.6 EUR |
Description: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities also include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation and the stimulation of acute-phase protein synthesis in hepatocytes. LIF activates JAK & STAT signaling in human embryonic stem (ES) cells, but this pathway does not maintain pluripotency in these cells, which instead rely on FGF2-mediated ERK signaling. By contrast, mouse ES cells can be maintained by LIF-mediated JAK & STAT signaling. LIF binds to a high affinity heterodimeric receptor complex consisting of two proteins: LIF-R alpha that binds LIF with low affinity and the 130kDa (gp130) subunit that by itself does not bind LIF, but is required for high affinity binding of LIF. |
|||
LIF Polyclonal Antibody |
|||
ABP52838-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Polyclonal Antibody |
|||
ABP52838-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Polyclonal Antibody |
|||
ABP52838-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF |
|||
LIF Polyclonal Antibody |
|||
ES3837-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
LIF Polyclonal Antibody |
|||
ES3837-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
LIF Receptor Antibody / LIFR |
|||
R32098 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: LIFR also known as CD118 (Cluster of Differentiation 118), is a subunit of a receptor for leukemia inhibitory factor. This gene encodes a protein that belongs to the type I cytokine receptor family. This protein combines with a high-affinity converter subunit, gp130, to form a receptor complex that mediates the action of the leukemia inhibitory factor, a polyfunctional cytokine that is involved in cellular differentiation, proliferation and survival in the adult and the embryo. Mutations in this gene cause Schwartz-Jampel syndrome type 2, a disease belonging to the group of the bent-bone dysplasias. A translocation that involves the promoter of this gene, t(5;8)(p13;q12) with the pleiomorphic adenoma gene 1, is associated with salivary gland pleiomorphic adenoma, a common type of benign epithelial tumor of the salivary gland. Multiple splice variants encoding the same protein have been found for this gene. |
|||
Rat LIF ELISA Kit |
|||
ERL0014 | Abclonal | 96Tests | 625.2 EUR |
Goat LIF ELISA Kit |
|||
EGTL0014 | Abclonal | 96Tests | 625.2 EUR |
Human LIF ELISA kit |
|||
55R-IB49639 | Fitzgerald | 96 wells | 1413.6 EUR |
Description: ELISA kit for the detection of LIF in the research laboratory |
|||
Human LIF ELISA kit |
|||
55R-2054 | Fitzgerald | 96 tests | 854.4 EUR |
Description: ELISA Kit for detection of LIF in the research laboratory |
|||
Mouse LIF ELISA Kit |
|||
EML0014 | Abclonal | 96Tests | 625.2 EUR |
Sheep LIF ELISA Kit |
|||
ESL0014 | Abclonal | 96Tests | 625.2 EUR |
Human LIF ELISA Kit |
|||
ELA-E0085h | Lifescience Market | 96 Tests | 988.8 EUR |
LIF ELISA KIT|Human |
|||
EF000330 | Lifescience Market | 96 Tests | 826.8 EUR |
Human LIF ELISA Kit |
|||
EHL0014 | Abclonal | 96Tests | 625.2 EUR |
Rabbit LIF ELISA Kit |
|||
ERTL0014 | Abclonal | 96Tests | 625.2 EUR |
Monkey LIF ELISA Kit |
|||
EMKL0014 | Abclonal | 96Tests | 625.2 EUR |
Bovine LIF ELISA Kit |
|||
EBL0014 | Abclonal | 96Tests | 625.2 EUR |
Canine LIF ELISA Kit |
|||
ECL0014 | Abclonal | 96Tests | 625.2 EUR |
Porcine LIF ELISA Kit |
|||
EPL0014 | Abclonal | 96Tests | 625.2 EUR |
Chicken LIF ELISA Kit |
|||
ECKL0014 | Abclonal | 96Tests | 625.2 EUR |
Anserini LIF ELISA Kit |
|||
EAL0014 | Abclonal | 96Tests | 625.2 EUR |
Human LIF shRNA Plasmid |
|||
20-abx952690 | Abbexa |
|
|
Mouse LIF shRNA Plasmid |
|||
20-abx971321 | Abbexa |
|
|
Recombinant Human LIF Protein |
|||
PROTP15018-5 | BosterBio | 25ug | 380.4 EUR |
Description: LIF is a pleiotrophic factor produced by multiple cell types including T cells, myelomoncytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant human LIF is a 19.6 kDa protein containing 180 amino acids residues including three disulfide bonds. |
|||
Recombinant Human LIF Protein |
|||
RP00089 | Abclonal | 10 μg | 208.8 EUR |
Recombinant Mouse LIF Protein |
|||
R01400-1 | BosterBio | 100ug/vial | 352.8 EUR |
Polyclonal LIF Antibody (Center) |
|||
APR05828G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Center). This antibody is tested and proven to work in the following applications: |
|||
LIF/Leukemia inhibitory factor |
|||
E21-017 | EnoGene | 10ug | 411.6 EUR |
LIF/Leukemia inhibitory factor |
|||
E21-690 | EnoGene | 10ug | 411.6 EUR |
Polyclonal LIF Antibody (Internal) |
|||
APR02876G | Leading Biology | 0.05mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Internal). This antibody is tested and proven to work in the following applications: |
|||
Lif ORF Vector (Rat) (pORF) |
|||
ORF069386 | ABM | 1.0 ug DNA | 607.2 EUR |
ELISA kit for Mouse LIF |
|||
EK5250 | SAB | 96 tests | 663.6 EUR |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse LIF in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Human LIF |
|||
EK5787 | SAB | 96 tests | 562.8 EUR |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human LIF in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Guinea Pig LIF ELISA Kit |
|||
EGL0014 | Abclonal | 96Tests | 625.2 EUR |
LIF ORF Vector (Human) (pORF) |
|||
ORF022709 | ABM | 1.0 ug DNA | 486 EUR |